Acquisition d'automate pour le suivi des biothérapies et des anticorps antimédicament libre et totaux avec fourniture des réactifs, consommables, accessoires et prestations associées
AI summary
This tender concerns the acquisition of an automated analyzer for monitoring biotherapies and free/total anti-drug antibodies, including supply of reagents, consumables, accessories, and associated services for CHU Amiens Picardie hospital laboratory.
Medical device manufacturers or authorized distributors with expertise in immunoassay automation and biotherapy monitoring solutions, able to provide comprehensive after-sales support.
Suppliers must provide a complete automated system capable of detecting and quantifying anti-drug antibodies, with technical support, training, and guaranteed supply of all reagents and consumables for the contracted period.
Frequently asked questions
What is this tender about?
This tender concerns the acquisition of an automated analyzer for monitoring biotherapies and free/total anti-drug antibodies, including supply of reagents, consumables, accessories, and associated services for CHU Amiens Picardie hospital laboratory.
What are the requirements for suppliers?
Suppliers must provide a complete automated system capable of detecting and quantifying anti-drug antibodies, with technical support, training, and guaranteed supply of all reagents and consumables for the contracted period.
What type of company should bid?
Medical device manufacturers or authorized distributors with expertise in immunoassay automation and biotherapy monitoring solutions, able to provide comprehensive after-sales support.
Who is the buyer?
The buyer is CHU AMIENS PICARDIE.
Documents not listed
Acquisition d'automate pour le suivi des biothérapies et des anticorps antimédicament libre et totaux avec fourniture des réactifs, consommables, accessoires et prestations associées.
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…